Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution.

Borovcanin, Milica M; Vesic, Katarina; Balcioglu, Y Hasan; Mijailovic, Natasa R

Borovcanin, Milica M; Vesic, Katarina; Balcioglu, Y Hasan; Mijailovic, Natasa R.

Afiliación

Borovcanin MM; Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Vesic K; Department of Neurology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Balcioglu YH; Department of Psychiatry, Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey.
Mijailovic NR; Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Front Psychiatry ; 13: 1052710, 2022.

Article en En | MEDLINE | ID: mdl-36339865

Palabras clave

COVID-19; SSRIs; adverse effect; antidepressants; inflammation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article Pais de publicación: CH / SUIZA / SUÍÇA / SWITZERLAND

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google